BioCorRx Company Description
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.
The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists.
It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid addiction and alcoholism.
The company licenses and distributes its program to healthcare providers and licensed healthcare professionals.
The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014.
BioCorRx Inc. is based in Anaheim, California.
| Country | United States |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Lourdes Felix |
Contact Details
Address: 2390 East Orangewood Avenue Anaheim, Nevada 92806 United States | |
| Phone | 714 462 4880 |
| Website | biocorrx.com |
Stock Details
| Ticker Symbol | BICX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US09073C2052 |
| SIC Code | 8093 |
Key Executives
| Name | Position |
|---|---|
| Lourdes Felix | Chief Executive Officer, Chief Financial Officer and Director |
| Louis Charles Lucido | President and Director |
| Dr. George N. Fallieras | Medical Consultant |